Patents by Inventor Akif Emre Tureli

Akif Emre Tureli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clevidipine nanoparticles and pharmaceutical compositions thereof
    Patent number: 11737989
    Abstract: Provided is a pharmaceutical composition comprising clevidipine in a sterile, ready to use, physically stable, aqueous dispersion of nanoparticles that stabilizes clevidipine against formation of impurities and is suitable for parenteral administration.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: August 29, 2023
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Rajeshwar Motheram, David C. Hanley, Sr., Akif Emre Tureli, Monika Kanter
  • CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20230145206
    Abstract: Provided is a pharmaceutical composition comprising clevidipine in a sterile, ready to use, physically stable, aqueous dispersion of nanoparticles that stabilizes clevidipine against formation of impurities and is suitable for parenteral administration.
    Type: Application
    Filed: November 29, 2022
    Publication date: May 11, 2023
    Inventors: Rajeshwar MOTHERAM, David HANLEY, Akif Emre TURELI, Monika KANTER
  • NANOPARTICLES COMPRISING A STABILIZED BORONIC ACID COMPOUND
    Publication number: 20180243217
    Abstract: The present invention provides nanoparticles comprising at least one boronic acid compound and at least one stabilizing agent for the at least one boronic acid compound and/or a reaction product of the at least one boronic acid compound and the at least one stabilizing agent, whereby the nanoparticles have a particle size of about 10 to about 1000 nm. The present invention also provides a pharmaceutical composition comprising these nanoparticles and a method for the preparation of these nanoparticles and the respective pharmaceutical compositions. In addition, the present invention provides nanoparticles and pharmaceutical compositions for the treatment of several disorders, especially multiple myeloma, preferably by parenteral administration.
    Type: Application
    Filed: March 11, 2016
    Publication date: August 30, 2018
    Inventors: Kathrin Ines MÜHLHÖLZL-ODÖRFER, Elke HORSTKOTTE, Sabine WEITENSTEINER, Isabel SOLE FONT, Akif Emre TÜRELI
  • Clevidipine Nanoparticles and Pharmaceutical Compositions Thereof
    Publication number: 20170087093
    Abstract: Provided is a pharmaceutical composition comprising clevidipine in a sterile, ready to use, physically stable, aqueous dispersion of nanoparticles that stabilizes clevidipine against formation of impurities and is suitable for parenteral administration.
    Type: Application
    Filed: May 19, 2015
    Publication date: March 30, 2017
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Rajeshwar Motheram, David C. Hanley, Sr., Akif Emre Tureli, Monika Kanter
  • Melatonin-based formulations for parenteral administration
    Patent number: 9468626
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: October 18, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani Raschini, Akif Emre Türeli, Eva Marie Prinz
  • MELATONIN-BASED FORMULATIONS FOR PARENTERAL ADMINISTRATION
    Publication number: 20150258064
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Application
    Filed: March 10, 2015
    Publication date: September 17, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani RASCHINI, Akif Emre TÜRELI, Eva Marie PRINZ